Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cubilin pseudogene 2 (CUBNP2) is a human pseudogene; it is designated as a genetic region with sequence similarity to the functional cubilin (CUBN) gene but does not encode an active protein. Pseudogenes, in general, are defunct genomic sequences similar to normal genes but typically lack the ability to produce functional proteins. While some pseudogenes are transcribed and may have regulatory roles or non-coding RNA functions, the majority—including CUBNP2—are not classical therapeutic targets, nor do they have recognized roles as enzymes, receptors, or transporters. There is no evidence that CUBNP2 encodes for a receptor or participates in endocytic, signaling, or disease-related biological processes. Its main significance is as a feature of the human genome used in studies of gene evolution or regulation[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cubilin pseudogene 2 (CUBNP2).